For decades, the Food and Drug Administration (FDA) had maintained a black box warning for hormone replacement therapy regarding estrogen. This often-prevented women from receiving appropriate estrogen hormone replacement therapy (HRT) either because of a history breast cancer or other health concern. This long-standing policy dated back decades to the Women’s Health Initiative study which failed to account for various individual factors such as type of estrogen, dose, and individual sensitivity. In this episode, Dr. Woeller has back on to the podcast Tracy Tranchitella, ND to discuss this very important change from the FDA and what it means for all women currently on HRT or seeking guidance for desired HRT treatment.

Check Out Dr. Woeller's Websites:
Functional Medicine DocTalk
Integrative Medicine Academy
Autism Recovery System
Sunrise Medical Center
Lab Tests Plus